InflaRx (IFRX) EBIT (2016 - 2026)

InflaRx has disclosed EBIT across 11 years of filings, most recently posting -$8.2 million for Q2 2026.

• In Q2 2026, EBIT rose 43.95% year-over-year to -$8.2 million; the TTM figure through Jun 2026 stood at -$42.7 million (up 58.08% YoY), while the FY2025 annual figure was -$54.5 million, up 3.74% from the prior year.
• EBIT came in at -$8.2 million for Q2 2026 at InflaRx, up from -$8.4 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$1.2 million in Q2 2022 to a low of -$56.6 million in Q4 2024.
• Average EBIT over 5 years is -$17.6 million, with a median of -$13.6 million recorded in 2024.
• Year-over-year, EBIT surged 93.11% in 2022 and plunged 825.6% in 2023.
• Over 5 years, EBIT stood at -$32.9 million in 2022, then tumbled by 46.91% to -$48.3 million in 2023, then dropped by 17.23% to -$56.6 million in 2024, then surged by 73.57% to -$15.0 million in 2025, then soared by 45.25% to -$8.2 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$8.2 million in Q2 2026, -$8.4 million in Q1 2026, and -$15.0 million in Q4 2025.